Inventor

KALLAND TERJE

SE9 patents

⚠️ This page may combine multiple inventors who share the name “KALLAND TERJE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PHARMACIA AB

3 patents

US6514498B1Feb 4, 2003

Modified/chimeric superantigens and their use

PHARMACIA AB99 citations95

US5776947AJul 7, 1998

Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock

PHARMACIA AB110 citations93

US5504092AApr 2, 1996

Use of Linomide to increase hemopoietic cell precursors

PHARMACIA AB38 citations88

ACTIVE BIOTECH AB

2 patents

US7226595B2Jun 5, 2007

Modified Chimeric superantigens and their use

ACTIVE BIOTECH AB69 citations95

US7226601B1Jun 5, 2007

Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate

ACTIVE BIOTECH AB13 citations82

ACTIVE BIOTECH AG

1 patent

US6962694B1Nov 8, 2005

Cytolysis of target cells by superantigen conjugates inducing T-cell activation

ACTIVE BIOTECH AG60 citations91

(unassigned)

1 patent

US6042837AMar 28, 2000

Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)

29 citations91

PHARMACIA & UPJOHN AB

1 patent

US6197299B1Mar 6, 2001

Antibody conjugates

PHARMACIA & UPJOHN AB46 citations89

KABI PHARMACIA AB

1 patent

US5691350ANov 25, 1997

Use of linomide for treatment of retrovirus infections specifically HIV infections

KABI PHARMACIA AB0 citations51